The FDA is requesting Gamida Cell for more data on the company’s wholly owned manufacturing facility before it can go ahead with asking for approval for omidubicel, its cell therapy for blood cancer ...
En route to seeking a second pivotal drug approval and after a clinical snag last month, BioMarin Pharmaceutical is beefing up its R&D and technical operations with a new chief medical officer and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback